العربية
Comprehensive Master Guide · Medically Reviewed

Arthritides Explained: Symptoms, Diagnosis, and Treatment Options

Arthritides ( Table 1.20 ) Osteoarthritis Progressive loss of cartilage structure and function Most common form of arthritis May be idiopathic May be secondary…

4 Detailed Chapters
13 min read
Updated: مارس 2026
Dr. Mohammed Hutaif
Medically Reviewed by
Prof. Dr. Mohammed Hutaif
Verified Content Expert Reviewed

Quick Medical Answer

We review everything you need to understand about Arthritides Explained: Symptoms, Diagnosis, and Treatment Options. Common arthritides arthritides arthritides, or joint inflammations, include noninflammatory types like osteoarthritis and neuropathic arthropathy, typically affecting the elderly with a male predominance. Other arthritides are acute rheumatic fever, common in children, and ochronosis, seen in adults. These conditions exhibit distinct age and sex incidence patterns for diagnostic differentiation.

Illustration of arthritides arthritides arthritides - Dr. Mohammed Hutaif
  1. ** Arthritides (** Table 1.20)
  2. Osteoarthritis
  3. Progressive loss of cartilage structure and function
  4. Most common form of arthritis
  5. May be idiopathic
  6. May be secondary to:
  7. Genetics ( Col2 defect); women affected more than men
  8. Overload: obesity, labor, dysplasia/femoral acetabular impingement, varus/valgus
  9. Trauma: fractures, ligament injuries, impact
  10. Tissue changes:
  11. Cartilage: enzymatic degradation and loss as discussed previously ( Fig. 1.30)
  12. Synovium: inflammation, vascular hypertrophy
  13. Ligaments: tightened on concave side of deformity
  14. Bone: sclerosis, osteophytes, and subchondral cysts
  15. Osteophyte formation due to pathologic activation of endochondral ossification by periarticular chondrocytes through Indian hedgehog (Ihh) mechanism

  16. Muscles: atrophied from inactivity
  17. Radiographic findings (Figs. 1.31 and 1.32)
  18. Joint space narrowing, often asymmetric, with osteophyte formation
  19. Eburnation of bone
  20. Subchondral cysts “geodes”
  21. Treatment discussed within individual chapters (see Chapter 5, Adult Reconstruction)
  22. Neuropathic arthropathy (Charcot joint disease)
  23. Extreme form of arthritis caused by disturbed sensory innervation
  24. Unstable, painless, swollen, red joint

  25. Effusion may show hemarthrosis
  26. Histologic findings: osteochondral fragments imbedded in synovium
  27. Less pain than would be expected radiographically
  28. Etiology: two theories
  29. Neuropathic loss of proprioception
  30. Repetitive trauma causes microfractures
  31. Hyperemia due to loss of sympathetic control
  32. Stimulates osteoclasts, weakens bones
  33. Radiographic findings ( Fig. 1.33)
  34. Severe destructive changes on both sides of the joint
  35. Scattered “chunks” of bone embedded in fibrous tissue
  36. Joint distension by fluid
  37. Heterotopic ossification
  38. Charcot arthropathy versus osteomyelitis
  39. May be difficult with physical examination and radiograph
  40. Both display swelling, warmth, and erythema and are common in diabetic patients
  41. Indium (In) 111–labeled WBC scan results
  42. “Hot” (positive) for osteomyelitis
  43. “Cold” (negative) for Charcot arthropathy
  44. Treatment includes bracing or casting (see Chapter 6)
  45. Neuropathic arthropathy also seen in
  46. Syringomyelia (see Fig. 1.33C and D)
  47. Most common cause of upper extremity neuroarthropathy
  48. 80% of cases in shoulder and elbow (see Fig. 1.33D)
  49. Joint disease develops in 25% of patients with syringomyelia.
  50. Leprosy (Hansen disease)
  51. Second most common cause in upper extremity
  52. Other neurologic problems
  53. Myelomeningocele: ankle and foot
  54. Spina bifida and spinal trauma (see Fig. 1.33G)
  55. Congenital insensitivity to pain
  56. Rheumatoid arthritis (see Table 1.20)
  57. Most common inflammatory arthritis
  58. Affects 0.5%–1% of population; three times more common in women
  59. 15% concordance rate in monozygotic twins
  60. Clinical presentation (see Fig. 1.32)
  61. Insidious subacute onset over 6 weeks
  62. Fatigue, malaise, anemia
  63. Morning stiffness and polyarthritis with swelling
  64. Hand and foot deformities are most common and are discussed in respective subsequent chapters
  65. Also common in the knees, elbows, shoulders, ankles, and cervical spine
  66. Subcutaneous rheumatoid nodules ( Fig. 1.34)
  67. Juxtaarticular erosions and periarticular osteopenia on radiographs
  68. 2010 American College of Rheumatology Classification Criteria for RA are summarized in Table 1.21.
  69. Diagnosis requires score 6 or more
  70. Criteria include
  71. Number of joints involved and duration of involvement
  72. Positive laboratory test results often found
  73. Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP)
  74. Pathogenesis
  75. Rheumatoid factor (RF) titer
  76. Antibody (immunoglobulin [Ig] M) against the Fc (crystallizable fragment) portion of IgG
  77. Positive result in about 80%
  78. Test for anticyclic citrullinated protein (anti-CCP) antibodies
  79. Also known as anti-CCP antibodies (ACPAs)
  80. Most sensitive and specific test (≈90% specific)
  81. Presence linked to more aggressive disease
  82. T cell–mediated immune response from an infectious or environmental antigen (smoking is one known trigger) in a genetically susceptible individual (HLA-DR4 and HLA-DW4)
  83. Mononuclear cells are primary mediator of RA tissue damage
  84. Initial response in soft tissues— neovascularization and synovitis
  85. CD4+ T lymphocytes (helper cells) activate synovial cells through direct cell-cell contact
  86. Synoviocytes produce cytokines
  87. Macrophages (type A): main source for TNF-α, IL-1
  88. Fibroblast (type B): main source for MMPs, proteases, and RANKL
  89. B lymphocytes (plasma cells): make RF, anti-CCP antibodies
  90. TNF-α, IL-1, IL-6, IL-7 upregulated
  91. IL-1: Regulator of inflammation and matrix destruction
  92. TNF-α:
  93. Upregulates endothelial adhesion molecules and stimulates angiogenesis
  94. Table 1.20 Comparison of Common Arthritides Age Incidence Arthritis Group By Sex Affected ---
    Noninflammatory Osteoarthritis | Elderly
    | M > F Neuropathic | Elderly
    | M > F Acute rheumatic fever | Children
    | M = F Ochronosis | Adults
    | M = F
    Inflammatory Rheumatoid | Young
    adults
    | F > M Systemic lupus erythematosus | Young
    adults
    | F > M Juvenile rheumatoid arthritis | Children
    | F > M Relapsing polychondritis | Elderly
    | M = F
    Spondyloarthropathies Ankylosing spondylitis | Young
    adults
    | M > F
    | | Reactive arthritis (Reiter syndrome) | Young
    adults
    | M > F
    | ---|---|---| Psoriatic | Young
    adults
    | M = F Enteropathic | Young
    adults
    | M > F Age Incidence Arthritis Group By Sex S Affected ---
    Crystal Deposition Disease Gout | Young
    | M > F
    | Chondrocalcinosis | Elderly
    | M = F
    | Infectious Pyogenic | All
    | M = F
    | Tuberculous | Elderly
    | M > F
    | Lyme disease | Young
    | M = F
    | Fungal | All
    | M > F
    | Hemorrhagic Hemophilia | Young
    | M
    | Sickle cell disease | Young
    | M = F
    | Pigmented villonodular synovitis | Young
    | M = F
    | ↓ , Decreased; AFB, acid-fast bacilli; ASO, antistreptolysin O; CPK, creatine phosphokinase; PTT, partial thromboplastin time.
    Illustration 1 for Arthritides Explained: Symptoms, Diagnosis, and Treatment Options
    --- FIG. 1.30 Enzyme cascade of IL-1–stimulated degradation of articular cartilage. TPA, Tissue plasminogen activator. From Simon SR, editor: Orthopaedic basic science, Rosemont, IL, 1994, American Academy of Orthopaedic Surgeons, p 40.
    Illustration 2 for Arthritides Explained: Symptoms, Diagnosis, and Treatment Options
    --- FIG. 1.31(A) Radiograph showing joint space narrowing, osteophytes, and bony sclerosis. (B) Macrosection of an osteoarthritic human femoral head demonstrating subarticular cysts, sclerotic bone formation, and a superior femoral head osteophyte. (C) Low-power micrograph of osteoarthritis showing fibrillation, fissures, and cartilage loss. D, Gross pathology of femoral head demonstrating cartilage thinning (1) ,
    subarticular cyst (2
    [“geode”]), and normal hyaline cartilage remaining (3) . A Courtesy Marc DeHart, MD, and Texas Orthopedics; B from Simon SR, editor: Orthopaedic basic science, Rosemont, IL, 1994, American Academy of Orthopaedic Surgeons; C and D from Horvai A: Bones, joints, and soft tissue tumors. In Kumar V et al, editors: Robbins and Cotran pathologic basis of disease, ed 9,
    Philadelphia, 2015,
    Elsevier, Fig. 26-93.
    Illustration 3 for Arthritides Explained: Symptoms, Diagnosis, and Treatment Options
    --- FIG. 1.32 Differences between rheumatoid arthritis and osteoarthritis. Left side of illustration demonstrates the main historical characteristics of RA, including symmetric involvement (both right and left joints as well as both medial and lateral compartments of the knees). Bilateral hand involvement is characteristic and usually involves wrist joints and proximal metacarpal joints. Right side of figure demonstrates osteoarthritis, which often is much more severe in one joint or one compartment of the knee. Hand involvement more commonly involves the distal interphalangeal joints (Heberden nodes) and proximal interphalangeal joints (Bouchard nodes) joints as well as the base of the thumb.
  95. Promotes influx of leukocytes and activates synovial fibroblasts
  96. Later response
  97. Promotes pain receptor pathways
  98. Drives osteoclastogenesis
  99. Synovial cells invade cartilage “pannus” and release MMPs, causing chondrolysis
  100. Periarticular bone erosions
  101. Cytokines stimulate osteoblasts and synovial B cells to make RANKL, which joins with RANK to activate osteoclasts. Responsible for bone destruction.
  102. Osteoclasts secrete cathepsin K and carbonic anhydrase.
    Illustration 4 for Arthritides Explained: Symptoms, Diagnosis, and Treatment Options
    Illustration 5 for Arthritides Explained: Symptoms, Diagnosis, and Treatment Options
    Illustration 6 for Arthritides Explained: Symptoms, Diagnosis, and Treatment Options
    Illustration 7 for Arthritides Explained: Symptoms, Diagnosis, and Treatment Options FIG. 1.33 Neuropathic arthritis. Arthritic degeneration due to lack of sensation can be caused by many diseases. All share radiographic findings that are more severe than the symptoms (often painless) and the fragments from bony destruction. Often findings take many years to develop. (A and B) Diabetic Charcot arthropathy of the foot is easily recognized by most of the industrialized world. (C and D) The most common cause of upper extremity neuropathic joint is syringomyelia ( syrinx = fluid-filled sac in central cord that causes insidious loss of pain and temperature early). (E–G) Tabetic arthropathy (tertiary syphilis) is the most common neuropathic arthritis of the knee and can often involve the hip.
    From Yablon CM et al: Areview of Charcot neuroarthropathy of the midfoot and
    hindfoot: what every radiologist needs to know, Curr Probl Diagn Radiol 39:187–199, 2010; Atalar AC et al: Neuropathic arthropathy of the shoulder associated with syringomyelia: a report of six cases, Acta Orthop Traumatol Turc 44:328–336, 2010; and Allali F et al: Tabetic arthropathy. Areport of 43 cases, Clin Rheumatol 25:858–860, 2006.
    Illustration 8 for Arthritides Explained: Symptoms, Diagnosis, and Treatment Options
    Illustration 9 for Arthritides Explained: Symptoms, Diagnosis, and Treatment Options
    Illustration 10 for Arthritides Explained: Symptoms, Diagnosis, and Treatment Options
    Illustration 11 for Arthritides Explained: Symptoms, Diagnosis, and Treatment Options FIG. 1.34 Upper extremity changes in common arthritis types. Left side of figure shows rheumatoid changes. (A) Swan neck deformity of index, middle, and ring fingers, with PIP joints extended and DIP joints flexed. (B) Boutonnière deformity: PIP joints flexed, DIP joints extended. (C) Bilateral wrist swelling with both ulnar metacarpal phalangeal joint deformities and swan neck deformities of fingers and left thumb. (D) Rheumatoid nodes noted on posterior olecranon region. Right side of figure shows osteoarthritic changes. (E) DIP changes (Heberden nodes) and PIP changes (Bouchard nodes). (F) Radiograph showing osteoarthritic changes at the base of the thumb. From O’Dell JD: Rheumatoid arthritis. In Goldman L, Schafer AI, editors: Goldman-
    Cecil medicine, Philadelphia, 2016, Elsevier, Fig. 264-3; Sweeney SE et al: Clinical features of rheumatoid arthritis. In Firestein GS et al: Kelley’s textbook of rheumatology, Philadelphia, 2013, Elsevier, Fig. 70-4; and http://medsci.indiana.edu/c602web/602/c602web/jtcs/docs/heber1.html
  103. Systemic manifestations
  104. Rheumatoid vasculitis
  105. Distal splinter hemorrhage
  106. Cutaneous ulcers (pyoderma gangrenosum)
  107. Visceral arteritis
  108. Pericarditis and pericardial effusion
  109. Pulmonary disease including nodules and fibrosis
  110. Felty syndrome: severe erosive RA with splenomegaly and leukopenia
  111. Treatments and their perioperative considerations
  112. Regimen variable and often employs multiple agents
  113. NSAIDs: help symptoms early—antiinflammatory effects
  114. Should be held for 7–10 days preoperatively.
  115. Low-dose steroids
  116. Decrease prostaglandins and leukotrienes
  117. Used initially as “bridge therapy” to disease-modifying antirheumatic drugs (DMARDs)
  118. “Stress dose” steroid should be used perioperatively for patients on longterm steroid therapy
  119. DMARDs
  120. Intended to address underlying autoimmune response
  121. Conventional DMARDs take 2–6 months to work
  122. Methotrexate: folate analogue
  123. Inhibits purine metabolism and T-cell activation
  124. Inhibits neovascularization
  125. Adverse reactions (ADRs): toxic to bone marrow, liver, and lung
  126. Usually can continue through surgery
  127. Azathioprine: immunosuppressive agent
  128. ADR: neutropenia
  129. Cyclosporine: immunosuppressive agent
  130. Inhibits activation of
    CD4+ T cells
  131. ADRs: nephrotoxicity, neurotoxicity, gingival hyperplasia
  132. Hydroxychloroquine (Plaquenil)
  133. Inhibits toll-like receptor 9 (TLR9)
  134. ADR: retinal toxicity (requires ophthalmology followup)
  135. Table 1.21 The 2010 ACR-EULAR Classification Criteria for Rheumatoid Arthritis Criteria Score ---
    A. Joint Involvement 1 Large Joint | 0 2–10 Large Joints | 1 1–3 Small Joints | 2 4–10 Small Joints | 3 > 10 Joints (at least 1 small joint) | 5
    B. Serology (at least 1 test result is needed) Negative RF and negative ACPA | 0 Low-positive RF or low-positive ACPA | 2 High-positive RF or high-positive ACPA | 3
    C. Acute-Phase Reactants (at least 1 test result is needed) Normal CRP and normal ESR | 0 Abnormal CRP or abnormal ESR | 1
    D. Duration of Symptoms < 6 weeks | 0 > 6 weeks | 1
    From Aletaha D et al: 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Arthritis Rheum 62:2569–2581, 2010.
  136. Usually can continue through surgery
  137. Sulfasalazine
  138. Decreases synthesis of inflammatory mediators
  139. ADRs: granulocytopenia, hemolytic anemia (glucose-6-phosphate dehydrogenase [G6PD])
  140. Usually can continue through surgery
  141. Minocycline
  142. Inhibits MMP collagenase
  143. ADR: cutaneous hyperpigmentation
  144. Biologic DMARDs
  145. Target TNF-α: etanercept, infliximab, adalimumab

  146. Targets IL-1: anakinra

  147. Targets CD20: rituximab
  148. Surgery should be scheduled at end of dosing cycle (e.g., in a patient taking etanercept schedule, surgery should occur the second week after the first withheld dose).
  149. Risks of opportunistic infection and lymphoma

  150. Surgical treatment is discussed within respective chapters.
  151. Juvenile idiopathic arthritis (JIA) is discussed in Chapter 3, Pediatric Orthopaedics.
  152. Systemic lupus erythematosus ( Fig. 1.35 ; see Table 1.20)
  153. Chronic inflammatory disease of unknown origin
  154. 90% of cases in women (blacks > whites)
  155. Initially mediated by tissue-binding autoantibodies and immune complexes (type III hypersensitivity)
  156. Pathophysiology
  157. Susceptible genetics stimulated by environment
  158. Immune system autoregulatory failure
  159. Sustained production of antibody to self-antigens
  160. Antinuclear antibodies (ANAs)—best screen; positive in 95%
  161. Anti-dsDNA, anti-Sm, anti-La (SS-B), antihistone antibodies—drug-induced lupus
  162. Immune complexes accumulate in various tissues and cause chronic inflammation
  163. Clinical findings
  164. Skin/joints—rash and arthritis
  165. Heart/kidney—pericarditis/nephritis
  166. Blood vessels—vasculitis
  167. Bone and joint involvement—most common feature
  168. Nonerosive polyarthritis affects over 75% (hand and wrist most common).
  169. Osteonecrosis (especially with steroids)
  170. Butterfly malar rash—classic feature
  171. Fever, pancytopenia
  172. Pharmacologic treatment similar to that for RA.
  173. Seronegative spondyloarthropathies
  174. Characterized by negative RF titer result and, often, positive HLA-B27 test result
  175. Symptoms
  176. Inflammatory back pain
  177. Peripheral arthritis
  178. Enthesitis—heel pain
  179. Dactylitis—sausage digit
  180. Eye—uveitis (iritis), conjunctivitis
  181. Skin, mucosal, GI, urethral
  182. Similar treatment routines, including NSAIDs, steroids, and DMARDs
  183. Ankylosing spondylitis (AS) ( Fig. 1.36 ; see Table 1.20)
  184. Male/female ratio 3:1; ages 20–40 years
  185. Most common in Northern European whites
  186. 90% HLA-B27 positive ( Table 1.22)
  187. Symptoms and findings
  188. Bilateral sacroiliitis (earliest symptom)
  189. Improves with exercise, not better with rest, pain at night
  190. Associated morning stiffness
  191. Progressive spinal flexion deformities over life
  192. Chin-on-chest deformity
  193. Modified Schober test (loss of lumbar flexion) (see Fig. 1.36C)
  194. Two marks are made10 cm apart over lumbar spine in erect patient.
  195. With patient in maximum spinal
    flexion, increase of less than 4 cm between marks indicates loss of flexion.
  196. Hip involvement at young age—poor prognosis
  197. Enthesitis: inflammation of tendon insertion
  198. Loss of chest expansion
  199. Uveitis: red, painful eye in 40%
  200. Aortic insufficiency and heart block
  201. Radiographic changes
  202. Squaring of the vertebrae
  203. Vertical syndesmophytes
  204. Bamboo spine
  205. Autofusion of sacroiliac joints (see Fig. 1.36B)
  206. Whiskering of the entheses
  207. Surgical treatment for AS is discussed within Chapter 8, Spine.
  208. Reactive arthritis (Reiter syndrome) ( Fig. 1.37 ; see Table 1.20)
  209. Classical triad presentation: “Can’t see, can’t pee, can’t climb a tree.”
  210. Young white males (18–40 years)
  211. Follows an infection at another site (hence “reactive”)
  212. Chlamydia, Shigella, Yersinia, Salmonella
  213. Findings
  214. Conjunctivitis, urethritis, and oligoarticular arthritis
    Illustration 12 for Arthritides Explained: Symptoms, Diagnosis, and Treatment Options
    Illustration 13 for Arthritides Explained: Symptoms, Diagnosis, and Treatment Options FIG. 1.35 Systemic lupus erythematosus. (A) Autoantibodies to DNA and DNA-binding proteins form immune complexes that stimulate immune system–directed inflammation throughout the body (type III hypersensitivity reaction). (B) Direct immunofluorescence with anti–immunoglobulin G antibodies shows immune complex deposits at two different places: a bandlike deposit along the epidermal basement membrane—positive result of lupus band test—and within the nuclei of the epidermal cells (ANAs). (C) Most patients have skin and joint involvement. The classic butterfly rash of SLE occurs in 10%–50% of patients with acute SLE. (D) The same immune complexes are seen in the basement membrane of the renal glomerulus. (E) Flea-bitten appearance of kidney specimen, with lupus nephritis causing various degrees of proteinuria, hematuria, and cellular casts. From Habif TP: Clinical dermatology, ed 5, St Louis,
    Mosby/Elsevier, 2009; Wikimedia Commons: Diffuse proliferative lupus nephritis.
    http://en.wikipedia.org/wiki/Lupus_nephritis#mediaviewer/File:Diffuse_pr oliferat
    ; and Wikimedia Commons: Lupus band test. http://en.wikipedia.org/wiki/Systemic_lupus_erythematosus#mediaviewer/File:L
  215. Sudden asymmetric swelling and pain in knee , ankle, hip
  216. May persist 3–5 months
  217. Feet affected more often than hands (heel pain)
  218. Calcaneal periostitis and metatars al head erosion
  219. Dactylitis: sausage digit of one finger/toe (see Fig.
    1.37E)
  220. 60% of patients with chronic disease have sacroiliitis.
  221. Painless mucocutaneous ulcers (penile) and oral stomatitis (see Fig. 1.37B)
  222. Urethritis (dysuria), prostatitis, or cervicitis
  223. Pustular lesions on the extremities, palms, and soles (keratoderma blennorrhagicum)
  224. Treatment: NSAIDs and PT
    Illustration 14 for Arthritides Explained: Symptoms, Diagnosis, and Treatment Options
    Illustration 15 for Arthritides Explained: Symptoms, Diagnosis, and Treatment Options
    Illustration 16 for Arthritides Explained: Symptoms, Diagnosis, and Treatment Options
    Illustration 17 for Arthritides Explained: Symptoms, Diagnosis, and Treatment Options FIG. 1.36 Ankylosing spondylitis is an axial seronegative spondyloarthropathy that causes progressive cervical and thoracic kyphosis and bamboo spine but has earliest involvement in the sacroiliac joints. (A) Early sacroiliitis demonstrated by loss of clarity and sclerosis in the lower third of the sacroiliac joints, particularly affecting the iliac side of the right sacroiliac joint (hip joints are normal). (B) Advanced disease with ankylosis or fusion of both the sacroiliac and hip joints. (C) Schober test; two marks made 10 cm apart on lumbar spine in erect stance should be less than 14 to 15 cm during forward flexion.
    From Raychaudhuri S: The classification and diagnostic criteria of ankylosing spondylitis, J
    Autoimmun 48–49:128–133, 2014.
  225. Psoriatic arthropathy (PsA) (see Table 1.20)
  226. Affects 5%–30% of patients with psoriasis
  227. Usually skin disease precedes arthritis
  228. Men and women (aged 30–40 years) equally affected
  229. Characteristic changes
  230. Distal interphalangeal (DIP) involvement (rare in other inflammatory arthritides)
  231. Nail changes in 90%
  232. Pitting, fragmentation, and discoloration
  233. 30% have sausage digits
  234. Prominent enthesitis and tenosynovitis
  235. Arthritis mutilans—most destructive form
  236. Telescoping (shortening) of digits
  237. Pathophysiology
  238. Upregulated RANKL in synovium (B-type cells)
  239. Marked increase in osteoclast precursors
  240. Radiographic findings
  241. Pencil-in-cup deformity, DIP
  242. Small joint ankylosis
  243. Osteolysis of metacarpal (MC) and phalangeal bone
  244. Periostitis and bony enthesitis
  245. Enteropathic arthritis (see Tables 1.20 and 1.22)
  246. Arthritis in presence of inflammatory bowel disease
  247. Varied clinical picture, but joint erosions uncommon
  248. 10%–50% of patients experience peripheral joint arthritis.
  249. Acute monoarticular synovitis precedes bowel symptoms.
  250. Nondeforming arthritis
  251. More common in large weight-bearing joints
  252. 10%–15% of cases associated with ankylosing spondylitis

Detailed Chapters & Topics

Dive deeper into specialized chapters regarding arthritides

4 Chapters
01
Chapter 1 26 min

Hyaluronic Acid for Osteoarthritis: Is Viscosity Supplementation Right?

viscosity supplementation-hyaluronic acid-OSTEOARTHRITIS OF THE KNEE Bone friction in the knee(OSTEOARTHRITIS OF THE KN…

02
Chapter 2 22 min

Glenohumeral Rheumatoid Arthritis & Septic Arthritis: Diagnosis, Anatomy & Management

Glenohumeral RA significantly raises septic arthritis risk. This guide covers diagnostic challenges, surgical anatomy, …

03
Chapter 3 11 min

Rheumatoid Arthritis: What You Need to Know About This Rheumatoid Condition

Rheumatoid arthritis (see Table 1.20 ) Most common inflammatory arthritis Affects 0.5%–1% of population; three times mo…

04
Chapter 4 10 min

Transform Your Joints: Techniques to help to reduce arthritis discomfort

Arthritis is a condition that affects the joints in the body, leading to inflammation, pain, and stiffness. It can be a…

Dr. Mohammed Hutaif
Medically Verified Content by
Prof. Dr. Mohammed Hutaif
Consultant Orthopedic & Spine Surgeon
Guide Overview